TUBERCULAR VACCINES CONTAINING RECOMBINANT VCG STRAINS, EXPRESSING ALANINE DEHYDROGENASE, SERINE DEHYDRATASE AND-OR GLUTAMINE SYNTHASE

FIELD: medicine, microbiology. ^ SUBSTANCE: invention concerns live vaccine recombinant strain Mycobacterium bovis-BCG, containing the nucleic acid, capable to express and coding, at least, one fiber or a polypeptide which shows alanine dehydrogenase activity, glutamine synthase activity or serine h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LJU TSZJUN, CHEHN' DZHEFFRI, ALEKSANDER DEHVID
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LJU TSZJUN
CHEHN' DZHEFFRI
ALEKSANDER DEHVID
description FIELD: medicine, microbiology. ^ SUBSTANCE: invention concerns live vaccine recombinant strain Mycobacterium bovis-BCG, containing the nucleic acid, capable to express and coding, at least, one fiber or a polypeptide which shows alanine dehydrogenase activity, glutamine synthase activity or serine hydratase activity. The corresponding amino-acid and nucleotide sequences are resulted in the description. The recombinant strain can contain all nucleic acid either its part, or the nucleic acid containing sequence, at least on 60 % identical sequence of the specified nucleic acid. The strain can be used for preparation of a pharmaceutical composition, in particular, vaccines or immunogene composition for treatment or prevention of a mammal against infection with micobacteria. The strain under the invention survives is better and is longer persists in an organism of the owner, inducing long protective immunity. ^ EFFECT: provision of more effective vaccines for prevention of tuberculosis and other infections caused by micobacteria. ^ 11 cl, 12 dwg, 2 tbl, 6 ex
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2339692C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2339692C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2339692C23</originalsourceid><addsrcrecordid>eNqNisEKgkAQQL10iOof5gP0ohB4HNdJF3Q2ZlfJk0hspyjBvqHvboWga6cH771t9HZdQaK6BgV6VEozWVCGHWrWXIGQMm2hGdlBryqwTkKxMdDlLGTt-mCD4SUoqR5KMRUxWorBkvwsuuAAuUyMQNV0Dts12oFdHco-2tym--IPX-4iOJFTdeLn5-iXebr6h3-N0qVZlh_zVKXZH8sHrTA-DA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TUBERCULAR VACCINES CONTAINING RECOMBINANT VCG STRAINS, EXPRESSING ALANINE DEHYDROGENASE, SERINE DEHYDRATASE AND-OR GLUTAMINE SYNTHASE</title><source>esp@cenet</source><creator>LJU TSZJUN ; CHEHN' DZHEFFRI ; ALEKSANDER DEHVID</creator><creatorcontrib>LJU TSZJUN ; CHEHN' DZHEFFRI ; ALEKSANDER DEHVID</creatorcontrib><description>FIELD: medicine, microbiology. ^ SUBSTANCE: invention concerns live vaccine recombinant strain Mycobacterium bovis-BCG, containing the nucleic acid, capable to express and coding, at least, one fiber or a polypeptide which shows alanine dehydrogenase activity, glutamine synthase activity or serine hydratase activity. The corresponding amino-acid and nucleotide sequences are resulted in the description. The recombinant strain can contain all nucleic acid either its part, or the nucleic acid containing sequence, at least on 60 % identical sequence of the specified nucleic acid. The strain can be used for preparation of a pharmaceutical composition, in particular, vaccines or immunogene composition for treatment or prevention of a mammal against infection with micobacteria. The strain under the invention survives is better and is longer persists in an organism of the owner, inducing long protective immunity. ^ EFFECT: provision of more effective vaccines for prevention of tuberculosis and other infections caused by micobacteria. ^ 11 cl, 12 dwg, 2 tbl, 6 ex</description><language>eng ; rus</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20081127&amp;DB=EPODOC&amp;CC=RU&amp;NR=2339692C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20081127&amp;DB=EPODOC&amp;CC=RU&amp;NR=2339692C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LJU TSZJUN</creatorcontrib><creatorcontrib>CHEHN' DZHEFFRI</creatorcontrib><creatorcontrib>ALEKSANDER DEHVID</creatorcontrib><title>TUBERCULAR VACCINES CONTAINING RECOMBINANT VCG STRAINS, EXPRESSING ALANINE DEHYDROGENASE, SERINE DEHYDRATASE AND-OR GLUTAMINE SYNTHASE</title><description>FIELD: medicine, microbiology. ^ SUBSTANCE: invention concerns live vaccine recombinant strain Mycobacterium bovis-BCG, containing the nucleic acid, capable to express and coding, at least, one fiber or a polypeptide which shows alanine dehydrogenase activity, glutamine synthase activity or serine hydratase activity. The corresponding amino-acid and nucleotide sequences are resulted in the description. The recombinant strain can contain all nucleic acid either its part, or the nucleic acid containing sequence, at least on 60 % identical sequence of the specified nucleic acid. The strain can be used for preparation of a pharmaceutical composition, in particular, vaccines or immunogene composition for treatment or prevention of a mammal against infection with micobacteria. The strain under the invention survives is better and is longer persists in an organism of the owner, inducing long protective immunity. ^ EFFECT: provision of more effective vaccines for prevention of tuberculosis and other infections caused by micobacteria. ^ 11 cl, 12 dwg, 2 tbl, 6 ex</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNisEKgkAQQL10iOof5gP0ohB4HNdJF3Q2ZlfJk0hspyjBvqHvboWga6cH771t9HZdQaK6BgV6VEozWVCGHWrWXIGQMm2hGdlBryqwTkKxMdDlLGTt-mCD4SUoqR5KMRUxWorBkvwsuuAAuUyMQNV0Dts12oFdHco-2tym--IPX-4iOJFTdeLn5-iXebr6h3-N0qVZlh_zVKXZH8sHrTA-DA</recordid><startdate>20081127</startdate><enddate>20081127</enddate><creator>LJU TSZJUN</creator><creator>CHEHN' DZHEFFRI</creator><creator>ALEKSANDER DEHVID</creator><scope>EVB</scope></search><sort><creationdate>20081127</creationdate><title>TUBERCULAR VACCINES CONTAINING RECOMBINANT VCG STRAINS, EXPRESSING ALANINE DEHYDROGENASE, SERINE DEHYDRATASE AND-OR GLUTAMINE SYNTHASE</title><author>LJU TSZJUN ; CHEHN' DZHEFFRI ; ALEKSANDER DEHVID</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2339692C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2008</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LJU TSZJUN</creatorcontrib><creatorcontrib>CHEHN' DZHEFFRI</creatorcontrib><creatorcontrib>ALEKSANDER DEHVID</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LJU TSZJUN</au><au>CHEHN' DZHEFFRI</au><au>ALEKSANDER DEHVID</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TUBERCULAR VACCINES CONTAINING RECOMBINANT VCG STRAINS, EXPRESSING ALANINE DEHYDROGENASE, SERINE DEHYDRATASE AND-OR GLUTAMINE SYNTHASE</title><date>2008-11-27</date><risdate>2008</risdate><abstract>FIELD: medicine, microbiology. ^ SUBSTANCE: invention concerns live vaccine recombinant strain Mycobacterium bovis-BCG, containing the nucleic acid, capable to express and coding, at least, one fiber or a polypeptide which shows alanine dehydrogenase activity, glutamine synthase activity or serine hydratase activity. The corresponding amino-acid and nucleotide sequences are resulted in the description. The recombinant strain can contain all nucleic acid either its part, or the nucleic acid containing sequence, at least on 60 % identical sequence of the specified nucleic acid. The strain can be used for preparation of a pharmaceutical composition, in particular, vaccines or immunogene composition for treatment or prevention of a mammal against infection with micobacteria. The strain under the invention survives is better and is longer persists in an organism of the owner, inducing long protective immunity. ^ EFFECT: provision of more effective vaccines for prevention of tuberculosis and other infections caused by micobacteria. ^ 11 cl, 12 dwg, 2 tbl, 6 ex</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2339692C2
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title TUBERCULAR VACCINES CONTAINING RECOMBINANT VCG STRAINS, EXPRESSING ALANINE DEHYDROGENASE, SERINE DEHYDRATASE AND-OR GLUTAMINE SYNTHASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T00%3A22%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LJU%20TSZJUN&rft.date=2008-11-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2339692C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true